Kymeta Interoperability with Kepler LEO Satellites Promises Powerful Connectivity of the Future with Kymeta™ u8 Terminal
Kymeta (www.kymetacorp.com), the communications company making mobile global, and Kepler Communications (www.kepler.space) announced today the successful demonstration of the Kymeta u8 Terminal with LEO satellite acquisition, tracking and throughput measurements, during extreme cold weather temperatures. The collaboration with Kepler supports Kymeta’s goal to develop solutions that are future proof with a clear LEO upgrade path and compatible with growing mega constellations.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210323005226/en/
Image of the Kymeta u8 Terminal in Inuvik, Canada during testing with Kepler LEO Satellites. (Photo: Business Wire)
In 2020, Kepler was selected for an extended u8 beta trial to capture the extended Northern winter in Inuvik, Canada. Frequent revisit times from the Kepler LEO satellites combined with the local environment of unprotected cold weather, snow, and ice provided a unique testing opportunity for the latest Kymeta technology. Results have demonstrated a significant increase in performance with lower latency, enhanced look angles and speeds that are approaching 10X faster than earlier products with higher throughput and total data passed.
The u8 system is designed to work down to -40oC. During testing, Kymeta and Kepler were able to update software facilitating the testing of new algorithms in real time. Updates included capabilities of on-board FPGA-based tracking receivers, which allowed for usage of channels more than 2 times larger than previous demonstrations.
Testing results exceeded expectations during these cold weather trials with average uplink and downlink speeds of 100 Mbps, providing the ability to transfer more than two gigabytes of data with each pass. Initial testing was completed using linear polarization on the u8 – in a future software upgrade the addition of circular polarization support will lead to additional increases in data transfer speeds.
“Kepler has been a great trial partner because they are agile and able to make adjustments for optimized performance at the same time we are adjusting the u8 terminal,” said David Harrower, Senior Vice President of Global Sales at Kymeta. “Many of our customers are interested in compatibility with LEO satellite services, and this testing helps ensure the longevity of the u8 and Kymeta Connect as well as offer a solution that takes advantage of the increased utility of LEO satellites.”
"The performance of the Kymeta u8 with Kepler's Global Data Service has exceeded our expectations," said Wen Cheng Chong, Kepler's CTO and Co-Founder. "Our recent testing and development efforts demonstrated not only the ability to move many more gigabytes of data than expected with each pass, but also the u8's ability to operate in polar environments, where many of Kepler's early adopters operate. With Kepler's recently increased capacity the u8 can serve customers globally, pole-to-pole and all points in between."
In January, Kepler launched 8 new satellites via SpaceX’s first dedicated SmallSat Rideshare Program. On March 22nd, Kepler launched an additional two satellites via the Soyuz-2, expanding its active constellation to 15 satellites in total. An additional launch is planned for June. Kymeta believes the collaboration with Kepler and further testing is instrumental to providing reliable connectivity and superior benefits to customers.
Kymeta next-generation solutions are built for mobility and designed specifically for the needs of global defense agencies, government, public safety, and commercial customers. Through the launch of the u8 and Kymeta Connect, the company has meaningfully increased antenna throughput and reduced the total cost of ownership. Its products offer a breakthrough in performance, ease of use, and hybrid satellite-cellular connectivity services.
Kymeta is unlocking the potential of broadband satellite connectivity, combined with cellular networks, to satisfy the overwhelming demand for comms on the move and making mobile global. Lepton Global Solutions, a Kymeta company, hosts the company’s satellite connectivity solutions and offers unique, complete, and turnkey bundled solutions to the market based on best-in-class technologies and tailored customer-centric services that meet and exceed customer mission requirements. These solutions in tandem with the company’s flat-panel satellite antenna, the first of its kind, and Kymeta Connect™ services provide revolutionary mobile connectivity on satellite and hybrid satellite-cellular networks to customers around the world. Backed by U.S. and international patents and licenses, the Kymeta terminal addresses the need for lightweight, slim, and high-throughput communication systems that do not require mechanical components to steer toward a satellite. Kymeta makes connecting easy – for any vehicle, vessel, or fixed platform.
Kymeta is a privately held company based in Redmond, Washington.
For more information, visit kymetacorp.com.
About Kepler Communications Inc.
Kepler is a satellite telecommunications provider based in Canada, backed by Costanoa Ventures, IA Ventures and other leading investors. Kepler’s mission is to connect people and things Everywhere, on earth and beyond. To this end, Kepler will build an in-space telecommunications network through an incremental deployment of products and technologies. The first to launch and operate a Ku-band satellite service in Low Earth Orbit, Kepler has expanded its capabilities with the successful commissioning of a cubesat production facility at their Toronto headquarters, from which the GEN 1 satellites are being delivered.
For more information, visit www.kepler.space and @KeplerComms.
Business Inquiries for Kymeta:
Vice President of Marketing and Communications
Media Inquiries for Kymeta:
Associated Director PR
The Summit Group
Business Inquires for Kepler:
Director, Sales & Marketing
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Colicity Inc. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing on or about April 16, 202116.4.2021 16:30:00 EEST | Press release
Colicity Inc. (the “Company”) announced that holders of the units sold in the Company’s initial public offering of 34,500,000 units, including the underwriters’ exercise of their full over-allotment option for 4,500,000 units, completed on February 26, 2021 (the “Offering”) may elect to separately trade the Class A common stock and warrants included in the units commencing on or about April 16, 2021. Any Units not separated will continue to trade on The Nasdaq Capital Market under the symbol “COLIU,” and the Class A common stock and warrants will separately trade on The Nasdaq Capital Market under the symbols “COLI” and “COLIW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into Class A common stock and warrants. This press release shall not constitute an o
Evobrutinib is the First and Only BTK Inhibitor to Demonstrate Reduction of a Key Biomarker of Neuronal Damage and Inflammation in Patients with MS16.4.2021 11:00:00 EEST | Press release
Merck, a leading science and technology company, will present data from a Phase II placebo-controlled randomized trial at the 2021 American Academy of Neurology (AAN) Annual Meeting showing that the investigational Bruton’s tyrosine kinase (BTK) inhibitor evobrutinib significantly reduced blood neurofilament light chain (NfL) levels, a key biomarker of neuronal damage and inflammation, in patients with multiple sclerosis (MS). Elevated blood NfL levels have been shown to be associated with damage to neurons and inflammation and may predict future brain atrophy and disease progression. “Blood NfL is a biomarker that may allow monitoring of disease activity and treatment response, which could be less burdensome and more sensitive than other standard clinical measures for MS patients,” said Prof. Jens Kuhle, MD, PhD, Head Multiple Sclerosis Centre, University Hospital Basel. “These data provide key insights into the role evobrutinib may play in modulating the clinical course of MS and fur
IFF Presents “Learning Labs” Video Series to Demonstrate Potential of New Company15.4.2021 23:15:00 EEST | Press release
IFF (NYSE: IFF) today introduced a new “Learning Labs” video series, featuring in-depth discussions with the leadership of the company’s segments and R&D function. Each video provides a comprehensive overview of IFF’s robust portfolio and enhanced capabilities following its recently completed merger with DuPont’s Nutrition and Biosciences (“N&B”) business. The complete “Learning Labs” series can be found here: ir.iff.com/events-presentations. In addition, IFF has also provided segment-level financial detail based on 2020 pro forma results. “As a global industry leader of high-value consumer ingredients, we are pleased to provide a closer look into our capabilities, operational model and future growth potential,” said Andreas Fibig, IFF Chairman and CEO. “Stakeholder communication remains essential to IFF’s continued growth, and since combining with N&B, we have continued to explore new ways to meaningfully connect with our investors. The insights shared through our ‘Learning Labs’ seri
Algorand and BridgeTower Capital Announce Strategic Partnership15.4.2021 23:14:00 EEST | Press release
BridgeTower Capital, a global private equity firm, focusing on traditional private equity investments and blockchain and DeFi markets, announced today a partnership with Algorand. Algorand, the creator of the world’s first pure proof-of-stake foundational blockchain, is a leading blockchain technology company accelerating the convergence of decentralized and traditional finance. BridgeTower will use Algorand’s technology as the underlying blockchain solution to issuance of the BridgeTower Capital tokenized digital security. It will also use Algorand as a preferred blockchain for BridgeTower products and services. Beyond the elementary requirement of an open, public network, Algorand’s technology enables a set of high performing Layer-1 blockchains that provide security, scalability, complete transaction finality, built in privacy, Co-Chains, and advanced smart contracts. “Algorand was a clear choice given their technology, team and leadership position in the digital marketplace,” said
BridgeTower Capital Launches Security Token Pre-Offering and Announces Global Expansion With Key Partners15.4.2021 19:00:00 EEST | Press release
BridgeTower Capital, a tokenized global private equity firm, has launched a private Security Token Pre-Offering (STO) culminating 12 months of work to purposefully assemble a team of world-class partners to participate in the blockchain infrastructure and services marketplace in the rapidly growing world of decentralized finance (DeFi). BridgeTower also announced it has formed a Zurich-based entity to further expand its current offering of blockchain infrastructure products and services. BridgeTower launched its Private -STO campaign earlier this week, which provides an opportunity for accredited investors to purchase shares in the company in the form of a digital security. BridgeTower has received active participation already and is seeking to raise $200 million in this initial raise. “We are seeing a global confluence of public and private digital finance markets being fueled by the adoption of blockchain technologies. This is creating unique opportunities for those who can assemble
Cryptology Asset Group p.l.c. successfully completes a share capital increase and sale of treasury shares and reviews options for financing further growth15.4.2021 17:49:00 EEST | Press release
Cryptology Asset Group p.l.c. (ISIN: MT0001770107; Ticker: CAP), a leading European investment company for blockchain- and crypto-related business models, has successfully completed its cash capital increase by issuing 128,375 new shares and the additional sale of the entire amount of 31,625 treasury shares to institutional investors. At a fixed price of EUR 200.00 per share each, the Company will receive total gross proceeds of EUR 32.0 million, which will be used to invest in new portfolio companies from the Cryptology pipeline. The Company is also exploring the possible acquisition of crypto assets, such as Bitcoin, as part of its treasury management strategy. To finance further growth, Cryptology is also currently reviewing various options to raise additional capital, such as through the issuance of a convertible or a straight bond. ICF BANK AG has been commissioned to conduct a market review. Management will make the final financing decision based on investor feedback and the prev
Cryptology Asset Group p.l.c. resolves a cash capital increase and sale of treasury shares15.4.2021 17:45:00 EEST | Press release
The Board of Directors of Cryptology Asset Group p.l.c. (ISIN: MT0001770107; Ticker: CAP) today resolved to increase the share capital of the Company by 128,375 new shares and to sell 31,625 treasury shares which is the entire position Cryptology holds of own shares after the buyback done over the last months. Shareholders' subscription rights to the new shares and the treasury shares are excluded. The Company has entered into binding subscription agreements for the entire amount of in total 160,000 shares with several institutional investors. Closing of the transaction is expected for end of April 2021. The capital increase will be carried out in cash contributions and by partially utilizing the existing authorized capital. The share capital of the Company is to be increased from EUR 2,732,500 to EUR 2,860,875 by issuing 128,375 new bearer shares of the Company ("New Shares"). The New Shares will be issued with a pro rata amount of capital stock of EUR 1.00 per share and with full div
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom